[1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Revised 2015. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available at: www.goldcopd.org. Last accessed on November 2, 2015.]Search in Google Scholar
[2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28:523–32.10.1183/09031936.06.00124605]Search in Google Scholar
[3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765–73.10.1016/S0140-6736(07)61380-4]Search in Google Scholar
[4. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341–51.10.1016/S0140-6736(11)60968-9]Search in Google Scholar
[5. Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, et al. Prevalence of nutritional depletion in large out-patient population of patients with COPD. Respir Med 2006; 100: 1349–55.10.1016/j.rmed.2005.11.02316412624]Search in Google Scholar
[6. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008; 31: 492-501.10.1183/09031936.0007480718310396]Search in Google Scholar
[7. Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000; 6: 110–5.10.1097/00063198-200003000-0000510741769]Search in Google Scholar
[8. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79–83.10.1164/rccm.200506-969OC16368793]Search in Google Scholar
[9. Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82:53–9.10.1093/ajcn/82.1.53]Search in Google Scholar
[10. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Am J Clin Nutr 2012; 95: 1385–95.10.3945/ajcn.111.02349922513295]Search in Google Scholar
[11. Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med 2006; 100: 561–7.10.1016/j.rmed.2005.05.02016019198]Search in Google Scholar
[12. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2013; 45: 2245–56.10.1016/j.biocel.2013.06.015]Search in Google Scholar
[13. Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol (1985) 2013; 114: 1253–62.10.1152/japplphysiol.00790.2012]Search in Google Scholar
[14. Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 54: 983–7.10.1093/ajcn/54.6.983]Search in Google Scholar
[15. Grönberg AM, Slinde F, Engström CP, Hulthén L, Larsson S. Dietary problems in patients with severe chronic obstructive disease. J Hum Nutr Diet 2005; 18: 445–52.10.1111/j.1365-277X.2005.00649.x]Search in Google Scholar
[16. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59: 574–80.10.1136/thx.2003.019588]Search in Google Scholar
[17. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153: 633–7.10.1164/ajrccm.153.2.8564110]Search in Google Scholar
[18. Koehler F, Doehner W, Hoernig S, Witt C, Anker SD, John M. Anorexia in chronic obstructive pulmonary disease-association to cachexia and hormonal derangement. Int J Cardiol 2007; 119: 83–9.10.1016/j.ijcard.2006.07.088]Search in Google Scholar
[19. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85–97.10.1038/nri2921]Search in Google Scholar
[20. Breyer MK, Rutten EP, Locantore NW, Watkins ML, Miller BE, Wouters EF. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease. Nat Rev Immunol 2011; 11: 85–97.]Search in Google Scholar
[21. Görek Dilektaşli A, Ulubay G, Bayraktar N, Eminsoy I, Oner Eyüboğlu F. The effects of cachexia and related components on pulmonary functions in patients with COPD. Tuberk Toraks 2009; 57: 298-305.]Search in Google Scholar
[22. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362: 217-27.10.1056/NEJMoa0808836]Search in Google Scholar
[23. Donahoe M. Nutritional support in advanced lung disease. The pulmonary cachexia syndrome. Clin Chest Med 1997; 18: 547-61.10.1016/S0272-5231(05)70401-9]Search in Google Scholar
[24. Balkom van RH, Heijden van der HF, Herwaarden van CL, Dekhuijzen PN. Corticosteroid induced myopathy of the respiratory muscles. Neth J Med 1994; 45: 114–22.]Search in Google Scholar
[25. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033–47.10.1093/ajcn/71.5.1033]Search in Google Scholar
[26. Schols AM, Wouters EF. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21: 753-62.10.1016/S0272-5231(05)70182-9]Search in Google Scholar
[27. Berthon BS, Wood LG. Nutrition and Respiratory Health—Feature Review. Nutrients 2015; 7: 1618–43.10.3390/nu7031618]Search in Google Scholar
[28. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 12:CD000998.10.1002/14651858.CD000998.pub3]Search in Google Scholar
[29. Cai B, Zhu Y, Ma Yi, Xu Z, Zao Yi, Wang J, et al. Comer G.M. Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients. Nutrition 2003; 19: 229–32.10.1016/S0899-9007(02)01064-X]Search in Google Scholar
[30. Shaheen SO, Jameson KA, Syddall HE, Aihie Sayer A, Dennison EM, Cooper C, et al. The relationship of dietary patterns with adult lung function and COPD. Eur Respir J 2010; 36: 277–84.10.1183/09031936.0011470920075056]Search in Google Scholar
[31. Rawal G, Yadav S, Shokeen P, Nagayach S. Medical nutrition therapy for the critically ill. Int J Health Sci Res 2015; 5: 384-93.]Search in Google Scholar
[32. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001; 36:1183–93.10.1007/s11745-001-0831-411795850]Search in Google Scholar
[33. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 2012; 7: e38934.10.1371/journal.pone.0038934338086322737223]Search in Google Scholar
[34. Sundar IK, Hwang JW, Wu S, Sun J, Rahman I. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun 2011; 406: 127–33.10.1016/j.bbrc.2011.02.011304984121300024]Search in Google Scholar
[35. Rawal G, Yadav S, Shokeen P. Health and the vitamin D. Int J Health Sci Res 2015; 5: 416-23.]Search in Google Scholar
[36. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44: 1504–20.10.1183/09031936.0007091425234804]Search in Google Scholar